RxCap
PrivateLast Round
Series B
Apr 25, 2024
Total Funding Raised
$19.7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RxCap is a healthtech company that provides a platform of connected remote monitoring solutions, including smart devices and software, to improve medication adherence and patient engagement for healthcare providers, payers, and pharmaceutical manufacturers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Patient Engagement, Telemedicine
Business Model
B2B2C
Customer Profile
Subscription SaaS, Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RxCap Comparables
Compare RxCap with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AdhereTech | 83% | |
| Vaica Medical | 82% | |
| InHandPlus | 79% |
RxCap Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 25, 2024 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 1205% MoM, reaching 2K.
- May 16, 2026
Monthly visitors increased 139% MoM, reaching 1.1K.
RxCap Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RxCap's valuation, stock price, and market status.
Is RxCap a public or private company?
RxCap is a private company.
What is the current stock price of RxCap?
RxCap is a private company, so its shares have no public market price. Caplight tracks RxCap's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RxCap worth (valuation)?
Valuation information for RxCap is not publicly available.
Can I buy RxCap stock?
RxCap shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RxCap's last funding round?
RxCap's most recent funding round was Series B on April 25, 2024.
Who are the main investors in RxCap?
Investor information for RxCap is not publicly disclosed.
Will RxCap IPO soon?
No public IPO plans have been announced for RxCap.
How can I track RxCap secondary market activity?
Caplight tracks bids, offers, and trades in RxCap's shares on secondary markets.